Could three doses a day prevent clots in pregnancy better than two?
NCT ID NCT04861103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking the blood thinner Lovenox three times a day works better than the standard twice-a-day schedule for pregnant women at high risk of blood clots. Pregnancy increases clot risk fivefold, and many women on the standard schedule don't get enough protection. The trial will enroll 12 pregnant women and measure blood thinner levels to see if three daily doses provide more consistent protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTICOAGULANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California Irvine
RECRUITINGOrange, California, 92868, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can DIY insulin algorithms match commercial systems for pregnant women with type 1 diabetes?
- Smart patch and coach app aim to tame diabetes in pregnancy
- New Decision-Making tool aims to prevent bleeding in blood thinner users
- Tighter blood sugar targets during pregnancy: could they protect newborns?
- New study tests simpler blood thinner regimen after heart procedure
- Should you pause your blood thinner before a heart procedure? a new study investigates.